[Developments in the serological diagnosis of malignant diseases].
The present study gives an evaluation of carcinoembryonic antigen (CEA), macrophage electrophoretic mobility test (MEM), sialyltransferase, galactosyltransferase isoenzyme (SGT), ribonuclease and reverse transcriptase as diagnostic aids in malignant diseases. CEA and sialyltransferase are of certain value in the monitoring of cancer, as their values in the serum may rise before progression of disease or relapse. Both tests are not reliable parameters in the early diagnosis of malignancy. Our results with regard to the MEM test have not proved in any way useful in the diagnosis of cancer. Our preliminary results appear to indicate that, provided further simplification of the method can be achieved, SGT isoenzyme determination seems to be a better means of diagnosing cancer. In view of inherent-methodological difficulties reverse transcriptase has, at present, no clinical application in the diagnosis of cancer.
D002272:Carcinoembryonic Antigen / Q000032:analysis; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis*; D012698:Serologic Tests
D002272:Carcinoembryonic Antigen
Entwicklungen in der blutchemischen diagnostik maligner erkrankungen.